» Articles » PMID: 6788293

Effect of Sulphonylurea on Insulin Secretion and Glucose Control in Insulin-treated Diabetics

Overview
Specialty General Medicine
Date 1981 Jul 25
PMID 6788293
Citations 3
Authors
Affiliations
Soon will be listed here.
Citing Articles

Tolbutamide does not alter insulin requirement in Type 1 (insulin-dependent) diabetes.

Ratzmann K, Schulz B, Heinke P, Besch W Diabetologia. 1984; 27(1):8-12.

PMID: 6147291 DOI: 10.1007/BF00253493.


Sulphonylurea and insulin: combined treatment in type 1 (insulin-dependent) diabetes.

Burke B Diabetologia. 1985; 28(3):182.

PMID: 3922830 DOI: 10.1007/BF00273870.


The insulin receptor concept and its relation to the treatment of diabetes.

Ward G Drugs. 1987; 33(2):156-70.

PMID: 3552593 DOI: 10.2165/00003495-198733020-00004.

References
1.
Kuzuya H, Blix P, Horwitz D, Steiner D, Rubenstein A . Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes. 1977; 26(1):22-9. DOI: 10.2337/diab.26.1.22. View

2.
Ludvigsson J, Heding L, LARSSON Y, Leander E . C-peptide in juvenile diabetics beyond the postinitial remission period. Relation to clinical manifestations at onset of diabetes, remission and diabetic control. Acta Paediatr Scand. 1977; 66(2):177-84. DOI: 10.1111/j.1651-2227.1977.tb07830.x. View

3.
Yue D, BAXTER R, Turtle J . C-peptide secretion and insulin antibodies as determinants of stability in diabetes mellitus. Metabolism. 1978; 27(1):35-44. DOI: 10.1016/0026-0495(78)90121-x. View

4.
Phillips M, Simpson R, Holman R, Turner R . A simple and rational twice daily insulin regime. Distinction between basal and meal insulin requirements. Q J Med. 1979; 48(191):493-506. View

5.
Prince M, Olefsky J . Direct in vitro effect of a sulfonylurea to increase human fibroblast insulin receptors. J Clin Invest. 1980; 66(3):608-11. PMC: 371691. DOI: 10.1172/JCI109894. View